Patents by Inventor Catherine Gonthier

Catherine Gonthier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • G-CSF polypeptides and uses thereof
    Patent number: 7863016
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: January 4, 2011
    Assignee: Merck Serono S.A.
    Inventors: Catherine Gonthier, Philippe Millasseau
  • G-CSF polypeptides and uses thereof
    Patent number: 7863018
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: January 4, 2011
    Assignee: Merck Serono SA
    Inventors: Catherine Gonthier, Philippe Millasseau
  • G-CSF polypeptides and uses thereof
    Patent number: 7790174
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: September 7, 2010
    Assignee: Merck Serono SA
    Inventors: Catherine Gonthier, Philippe Millasseau
  • G-CSF POLYPEPTIDES AND USES THEREOF
    Publication number: 20090275518
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Application
    Filed: June 26, 2009
    Publication date: November 5, 2009
    Applicant: Merck Serono S.A.
    Inventors: CATHERINE GONTHIER, Philippe Millasseau
  • G-CSF POLYPEPTIDES AND USES THEREOF
    Publication number: 20090275517
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Application
    Filed: June 26, 2009
    Publication date: November 5, 2009
    Applicant: MERCK SERONO S.A.
    Inventors: CATHERINE GONTHIER, PHILIPPE MILLASSEAU
  • KCNQ2-15 potassium channel
    Patent number: 7442519
    Abstract: The invention encompasses polypeptides and polynucleotides of three novel bipolar disorder-associated potassium channel polypeptides, KCNQ2-15bx, KCNQ2-15by and KCNQ2-15bz. The invention further relates to the use of potassium channels comprising KCNQ2 subunits for screening for modulators thereof, the use of these modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression, and drugs comprising these modulators. The invention also discloses biallelic markers located in the KCNQ2 gene and their use for diagnosing mental disorders.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: October 28, 2008
    Assignee: Serono Genetics Institute, S.A.
    Inventors: Laurent Cavarec, Ilya Chumakov, Benoit Destenaves, Catherine Gonthier, Isabelle Elias
  • G-CSF Polypeptides And Uses Thereof
    Publication number: 20080145377
    Abstract: The present invention relates to G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
    Type: Application
    Filed: December 21, 2005
    Publication date: June 19, 2008
    Applicant: LABORATORIES SERONO S.A.
    Inventors: Catherine Gonthier, Philippe Millasseau
  • Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
    Publication number: 20060099210
    Abstract: The invention encompasses polypeptides and polynucleotides of three novel bipolar disorder-associated potassium channel polypeptides, KCNQ2-15bx, KCNQ2-15by and KCNQ2-15bz. The invention further relates to the use of potassium channels comprising KCNQ2 subunits for screening for modulators thereof, the use of these modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression, and drugs comprising these modulators. The invention also discloses biallelic markers located in the KCNQ2 gene and their use for diagnosing mental disorders.
    Type: Application
    Filed: June 20, 2003
    Publication date: May 11, 2006
    Applicant: Serono Genetics Institute S. A.
    Inventors: Laurent Cavarec, Ilya Chumakov, Benoit Destenaves, Catherine Gonthier, Isabelle Elias